Search

everythinglearnresearchcommunity

for

Search:↓

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Skin fat helps with body temperature control and has other active roles in health.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

HIV can cause unusual and severe skin problems that are hard to treat.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Removing the thymoma improved the man's autoimmune conditions.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Recent advances in hair loss treatments show significant progress.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Women with early onset androgenetic alopecia have worse lipid profiles.

Leflunomide and anthralin may effectively treat severe alopecia areata.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Rhododendrol in skin-whitening products can cause skin depigmentation and immune reactions.

Several new treatments for different types of hair loss show promise in improving patient quality of life.